Richter Transformation Lymphoma Recruiting Phase 2 Trials for Nemtabrutinib (DB18866)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0117440 (Richter Transformation Lymphoma) | Recruiting | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT05458297 | A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006) | Treatment |